ARCHIVES

NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation

November 14, 1997

Tracors’ Prime Contract Includes $1 Million for Additional Tests

May 17, 1974

HHS Orders Gallo Forum Canceled; Meeting May Be Held After OSI report final – Calabresi

July 3, 1992

CCIRC Members Now Feel At Home In DCT

March 3, 1978

DCPC Advisors Okay Continuation of Children’s Diet Study

January 31, 1992